Association between point-of-care ultrasound and falls: evidence from children with asthma
Published
January 1, 2024
Paper ID
PAP-000131
Status
Published
DOI
10.65712/tmj.test000389
Advance Services
Abstract
Background: falls remains a leading cause of avoidable harm among children with asthma. Methods: The primary outcome was falls, assessed blind to allocation. Results: Serious adverse events were rare and similar between groups. Serious adverse events were rare and similar between groups. Conclusion: Future work should test point-of-care ultrasound in a pragmatic multicentre trial.
Introduction
falls remains a leading cause of avoidable harm among children with asthma. Earlier studies of point-of-care ultrasound were small or single-centre. Guidelines make only a weak recommendation on point-of-care ultrasound.
falls remains a leading cause of avoidable harm among children with asthma. Earlier studies of point-of-care ultrasound were small or single-centre.
The cost of falls to health systems is substantial. Earlier studies of point-of-care ultrasound were small or single-centre.
Discussion
These findings suggest that point-of-care ultrasound is associated with better falls in children with asthma. Implementation will depend on staffing, cost and local protocols. Future work should test point-of-care ultrasound in a pragmatic multicentre trial.
Implementation will depend on staffing, cost and local protocols. These findings suggest that point-of-care ultrasound is associated with better falls in children with asthma.
Future work should test point-of-care ultrasound in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
Implementation will depend on staffing, cost and local protocols. These findings suggest that point-of-care ultrasound is associated with better falls in children with asthma. Strengths include the sample size and blinded outcome assessment.
Conclusions
Point-of-care ultrasound merits wider use for children with asthma to improve falls.
References
1. Farouk Y, Costa I, et al. Delayed cord clamping and ventilator-free days. Pediatrics. 2023;347(4):816-917.
2. Haddad A, Mueller Y, et al. An enhanced recovery pathway and length of stay. Pediatrics. 2015;280(2):433-1201.
3. Haddad T, Nasser E, et al. Continuous glucose monitoring and acute kidney injury. Pediatrics. 2022;396(10):388-1296.
4. Osei I, Okafor G, et al. Vitamin D supplementation and emergency department revisits. N Engl J Med. 2021;156(4):834-1583.
5. Dubois R, Mensah F, et al. Home-based cardiac rehabilitation and length of stay. N Engl J Med. 2011;17(6):533-1272.
6. Zhang A, Larsen B, et al. Vitamin D supplementation and acute kidney injury. Crit Care Med. 2010;276(12):169-1238.
7. Mensah T, Kaur S, et al. Frailty screening and chronic pain scores. Lancet. 2023;312(1):275-1243.
8. Kaur W, Dubois W, et al. Early enteral nutrition and length of stay. JAMA. 2022;236(10):158-1556.
Appendices
Ethics approval: IRB-8722.
Materials and Methods
Eligible participants were children with asthma. The primary outcome was falls, assessed blind to allocation.
We conducted a randomised controlled trial across 5 centres between 2020 and 2025. Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
Analyses were adjusted for age, sex and baseline severity. The primary outcome was falls, assessed blind to allocation.
Missing data were handled with multiple imputation. The primary outcome was falls, assessed blind to allocation.
Results
Serious adverse events were rare and similar between groups.
falls occurred in 16% of the intervention group versus 36% of controls. The adjusted odds ratio was 0.83 (95% CI 0.33 to 0.89).
2050 participants were included (median age 28 years). Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Age ≥ 65 | 110 | 26 | 29.0 | 0.48 | 0.25–1.20 |
| Centre A | 206 | 84 | 25.7 | 0.53 | 0.20–1.3 |
| Intervention | 786 | 75 | 36.3 | 0.48 | 0.29–1.26 |
Values are n (%) unless stated otherwise.

Shown for children with asthma; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. falls occurred in 15% of the intervention group versus 18% of controls.